SCHEMBL305895

SCHEMBL305895

CC(O)NC(=O)OC(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA7 P43166 1/20 0.55
CYP2D6 P10635 1/20 0.53
CTSK P43235 9/20 0.47
CTSS P25774 5/20 0.46
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
KMT2A Q03164 3/20 0.42
CA12 O43570 1/20 0.42
CA14 Q9ULX7 1/20 0.42
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
PREP P48147 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10652 0.83 CA1 (0.57) CA1CA2CA7CYP2D6CTSK
SCHEMBL24069882 0.83 CA1 (0.57) CA1CA2CA7CYP2D6CTSK
SCHEMBL6131580 0.82 CA1 (0.52) CA1CA2CA7CYP2D6CTSK
SCHEMBL20725932 0.82 CA1 (0.52) CA1CA2CA7CYP2D6CTSK
SCHEMBL30660637 0.82 CA1 (0.52) CA1CA2CA7CYP2D6CTSK
SCHEMBL23622224 0.82 CA1 (0.52) CA1CA2CA7CYP2D6CTSK
SCHEMBL19102018 0.82 CA1 (0.52) CA1CA2CA7CYP2D6CTSK
SCHEMBL1250920 0.82 CA1 (0.52) CA1CA2CA7CYP2D6CTSK
SCHEMBL13508405 0.82 CA1 (0.52) CA1CA2CA7CYP2D6CTSK
SCHEMBL8089855 0.82 CA1 (0.52) CA1CA2CA7CYP2D6CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 664 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115554409-B Polymer carrier material with mitochondrial targeting and preparation method and application thereof 湖北科技学院 2024-08-06 CN claimed
CN-118084734-A Preparation method of O- [2- [ [ tert-butoxycarbonyl ] amino ] ethyl ] -N- [ fluorenylmethoxycarbonyl ] -L-tyrosine 成都海杰亚医药科技有限公司 2024-05-28 CN claimed
CN-113956601-B Preparation of hydrophobic-electrostatic multifunctional nano composite micelle and application thereof in protease protection 南开大学 2024-04-02 CN claimed
CN-116943408-B Hindered amine composite desulfurizing agent and preparation method thereof 江苏创新石化有限公司 2024-01-30 CN claimed
CN-116943408-A Hindered amine composite desulfurizing agent and preparation method thereof 江苏创新石化有限公司 2023-10-27 CN claimed
CN-115926658-B Environment-friendly transparent self-adhesive film and preparation method thereof 广东金榜膜业科技有限公司 2023-09-22 CN claimed
CN-115926658-A Environment-friendly transparent self-adhesive film and preparation method thereof 广东金榜膜业科技有限公司 2023-04-07 CN claimed
CN-115850677-A Single-component organic Lewis acid-base pair and method for synthesizing polyacetal ether polyol 青岛科技大学 2023-03-28 CN claimed
CN-115304893-B Degradable starch-based plastic and preparation method thereof 上海盛凯塑胶制品有限公司 2023-02-24 CN claimed
CN-115304893-A Degradable starch-based plastic and preparation method thereof 上海盛凯塑胶制品有限公司 2022-11-08 CN claimed
CN-109675087-A It is a kind of detumescence, antibacterial analgesic soluble stanching gauze 余标 2019-04-26 CN claimed
CN-107513145-A The synthesis of biodegradable amphiphilic block class antibacterial peptide and the preparation method and application of class antibacterial peptide vesica 同济大学 2017-12-26 CN claimed
US-20170145042-A1 CYSTEINE-MODIFYING SUBSTRATE ANALOGUE INHIBITORS OF RIBOSE 5-PHOSPHATE ISOMERASE FOR PARASITIC DISEASES, ALONG WITH METHODS OF THEIR FORMATION AND USE UNIVERSITY OF SOUTH CAROLINA 2017-05-25 US claimed
EP-2088865-B1 GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS JINA PHARMACEUTICALS INC (US) 2015-10-21 EP claimed
EP-2114866-A2 GLYCEROL ESTER-FREE FUNCTIONALIZED VEGETABLE OIL DERIVATIVES AND THEIR LATEX COMPOSITIONS University of Southern Mississippi (US) 2009-11-11 EP claimed
WO-2008094503-A2 GLYCEROL ESTER-FREE FUNCTIONALIZED VEGETABLE OIL DERIVATIVES AND THEIR LATEX COMPOSITIONS UNIVERSITY OF SOUTH MISSISSIPPI (US) 2008-08-07 WO claimed
US-20080183000-A1 Glycerol ester-free functionalized vegetable oil derivatives and their latex compositions UNIVERSITY OF SOUTHERN MISSISSIPPI, THE 2008-07-31 US claimed
EP-0530285-B1 PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF PHENYLISOSERIN DERIVATIVES RHONE POULENC RORER SA (FR) 1994-08-10 EP claimed
EP-0530285-A1 PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF PHENYLISOSERIN DERIVATIVES. RHONE POULENC RORER SA (FR) 1993-03-10 EP claimed
WO-1991017976-A1 PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF PHENYLISOSERIN DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1991-11-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080183000-A1 Glycerol ester-free functionalized vegetable oil derivatives and their latex compositions HDHD5, MGLL, ABHD6 CA1 4305/4885CA2 4692/4885CA7 4478/4885
US-20170145042-A1 CYSTEINE-MODIFYING SUBSTRATE ANALOGUE INHIBITORS OF RIBOSE 5-PHOSPHATE ISOMERASE FOR PARASITIC DISEASES, ALONG WITH METHODS OF THEIR FORMATION AND USE RPIA, PRPS1, MPI CA1 2198/4885CA2 1629/4885CA7 2138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.